Total Return chart Sprint Bioscience AB

Stocks

Delayed Nasdaq Stockholm 11:24:54 2026-10-15 EDT			5-day change	1st Jan Change
3.600 ^SEK	-6.01%		-1.37%	+144.22%

08-26	Sprint Bioscience AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-23	Sprint Bioscience AB and Eli Lilly and Company Enter Agreement to Accelerate Drug Development	CI

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.